Home Tags Neurodegenerative Diseases
Neurodegenerative Diseases Related Content
Suffering childhood trauma, either psychologically or physically, can increase the risk of mental disorder development in adulthood by as much as three times.
COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
Tim Wooller, Principal – Industrial Design, Sector Lead Healthcare, PDD, explores how AI can help treat diseases such as cancer and stroke.
Alzheimers drugs have been shown able to target insulin receptors located in cerebral microvessels, massively expanding the future of drug production and testing
Fact or science fiction? A groundbreaking study has shown that human brain cells in a dish can play the video game Pong.
Diabetic retinopathy is the real medical term for diabetic eye disease. It is the most common cause of blindness in people of working age. 94 million people are affected worldwide.
Experiences of racial discrimination increase the risk of physical and mental illnesses and health disorders for people of colour.
Long-term, high-fat diets both expand the waistline and shrink the brain, heightening the chances of mental illness for people with obesity.
European Brain Council outlines the priorities for the future when it comes to improving the lives of people with brain disorders.
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
Dr Tara DeSilva discusses her work in neurosciences at the Cleveland Clinic and Case Western Reserve University School of Medicine
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, addresses cerebral creatine deficiency syndrome through genetic treatments.
Dr Roger J. Young, Professor at Saba University School of Medicine, walks us through Brittle Bone Disease, otherwise known as Osteogenesis Imperfecta Type I.
Adonis Sfera and Zisis Kozlakidis provide recent insights into cellular and biological pathways from studies on communicable diseases.
Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.
Maxine Smeaton, Chief Executive of Epilepsy Research UK delves into the common yet complex connections between brain tumours and seizures.
Jacqueline Hoogendam, JPND’s newly elected Vice-Chair and Executive Board member talks about JPND’s past and present strategies in its outreach campaign within and beyond Europe.
The Del Monte Institute for Neuroscience have been shedding light on how health brains are able to multitask while walking